TC
ISEE

Trium Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Trium Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-113,600
Closed -$4.47M – 102
2023
Q2 		$4.47M Buy
+113,600
New +$4.01M 0.95% 27

Trium Capital's ISEE Position: Q3 2023 in Review

Trium Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 245,597 shares — an estimated $9.66M sold.

Trium Capital first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $9.66M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Trium Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Trium Capital sold 245,597 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $9.66M.
  • Trium Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Trium Capital's IVERIC bio, Inc. Common Stock position peaked at $9.66M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Trium Capital's 13F filing for Q3 2023, filed 6 Nov 2023.